Shelly Ikeme is currently the Global Head of Market Access at Baxter where she supports the entire global Surgical Care franchise. In Shelly’s current role at Baxter, she is tasked with the responsibility of developing and implementing the overall Surgical Care franchise global market access strategy through collaboration with country and international market access staff, marketing and medical affairs teams. Prior to Baxter, Shelly served in various Health Economics role at Sanofi (Oncology) and Bristol Myers Squibb (Immunology), where she leveraged her health economics and outcomes research (HEOR) expertise in the development of pharmacoeconomic tools to drive the communication of product’s economic and humanistic value to a wide range of external stakeholders, including providers, payers, and policymakers. Shelly received both her Doctorate of Pharmacy and MBA degrees from Temple University and a Master’s in Public Health in Health Economics & Policy from Johns Hopkins University. Shelly is presently completing a PhD in Applied Health Economics & Outcomes Research from Thomas Jefferson University in Philadelphia.